Omnicell (NASDAQ: OMCL)
Omnicell Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Omnicell Company Info
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
News & Analysis
Why Shares of Omnicell Dropped 33.6% This Week
The healthcare medication management company released lowered guidance.
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These companies have a history of creating shareholder value -- and still have plenty of room for growth.
Omnicell Floating $500 Million Convertible Notes Issue
The company hasn't yet set the price, interest rate, or other key terms for the securities.
Why GameStop, Omnicell, and Cadiz Slumped Today
Despite the Dow hitting 27,000 for the first time, not every stock participated in the rally.
Why Omnicell Is Soaring Today
Traders cheer after the company reports upbeat quarterly results and shares bullish guidance. Here's what investors need to know.
Why Omnicell Is a Strong Under-the-Radar Stock
Omnicell might be flying under the radar, but it's part of a disrupting sector with much growth potential.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.